Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients

Transplant Proc. 1996 Dec;28(6):3183-4.
No abstract available

MeSH terms

  • Antilymphocyte Serum / therapeutic use
  • Chronic Disease
  • Cyclosporine / therapeutic use*
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Graft Rejection / drug therapy
  • Graft Rejection / epidemiology*
  • Graft Rejection / mortality
  • Graft Survival
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Incidence
  • Liver Transplantation / immunology*
  • Liver Transplantation / mortality
  • Reoperation
  • Retrospective Studies
  • Survival Rate
  • Tacrolimus / therapeutic use*
  • Treatment Outcome

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Cyclosporine
  • Tacrolimus